DMRAHealthcare
Damora Therapeutics, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Damora Therapeutics, Inc. (DMRA), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are DMRA insiders buying or selling?
Damora Therapeutics, Inc. insiders reported 15 open-market buys ($28.1M) and 16 sells ($2.2M) across 31 Form 4 filings — a net buying position of $25.9M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 8, 2026)
Total Form 4 filings
31
SEC EDGAR
Insider filers
9
Insider buys (15)
$28.1M
Insider sells (16)
$2.2M
Insider sentiment
Net buyingNet insider flow of $25.9M in net buying.
Recent DMRA insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 8, 2026 | Garrett Winslow | General Counsel | Sale | 245 | $29.98 | $7.3K |
| Jan 6, 2026 | Hans T. Schambye | Chief Executive Officer | Sale | 700 | $21.38 | $15.0K |
| Jan 6, 2026 | Garrett Winslow | General Counsel | Sale | 255 | $21.38 | $5.5K |
| Jan 6, 2026 | Lori Firmani | Chief Financial Officer | Sale | 135 | $21.41 | $2.9K |
| Jul 8, 2025 | Hans T. Schambye | Chief Executive Officer | Sale | 735 | $3.38 | $2.5K |
| Jul 8, 2025 | Garrett Winslow | General Counsel | Sale | 260 | $3.39 | $881.4 |
| Jul 8, 2025 | Lori Firmani | Interim CFO | Sale | 147 | $3.39 | $498.33 |
| Jan 7, 2025 | Garrett Winslow | General Counsel | Sale | 471 | $5.60 | $2.6K |
| Jan 7, 2025 | Lori Firmani | Interim CFO | Sale | 261 | $5.63 | $1.5K |
| Jan 7, 2025 | Hans T. Schambye | Chief Executive Officer | Sale | 1.3K | $5.60 | $7.5K |
| Aug 17, 2023 | ORBIMED ADVISORS LLC | 10% Owner | Sale | 822.7K | $0.75 | $617.0K |
| Aug 2, 2023 | ORBIMED ADVISORS LLC | 10% Owner | Sale | 209.4K | $3.00 | $628.2K |
| Jul 17, 2023 | ORBIMED ADVISORS LLC | 10% Owner | Sale | 194.7K | $2.40 | $467.3K |
| Apr 17, 2023 | ORBIMED ADVISORS LLC | 10% Owner | Sale | 68.5K | $1.87 | $128.3K |
| Apr 12, 2023 | ORBIMED ADVISORS LLC | 10% Owner | Sale | 67.5K | $1.80 | $121.4K |
| Apr 7, 2023 | ORBIMED ADVISORS LLC | 10% Owner | Sale | 102.6K | $2.16 | $222.0K |
| Mar 23, 2022 | Bertil Lindmark | Chief Medical Officer | Purchase | 14.6K | $2.16 | $31.5K |
| Mar 23, 2022 | Hans T. Schambye | Chief Executive Officer | Purchase | 5.0K | $2.15 | $10.8K |
| Dec 6, 2021 | Garrett Winslow | General Counsel | Purchase | 2.0K | $2.48 | $5.0K |
| Dec 6, 2021 | Jonathan Freve | Chief Financial Officer | Purchase | 4.0K | $2.49 | $10.0K |
| Nov 10, 2021 | Hans T. Schambye | Chief Executive Officer | Purchase | 4.5K | $3.50 | $15.8K |
| Nov 9, 2021 | Jonathan Freve | Chief Financial Officer | Purchase | 3.0K | $3.40 | $10.2K |
| Aug 19, 2021 | Jonathan Freve | Chief Financial Officer | Purchase | 3.0K | $3.92 | $11.8K |
| Jun 28, 2021 | Bertil Lindmark | Chief Medical Officer | Purchase | 2.0K | $5.26 | $10.5K |
| Jun 24, 2021 | Hans T. Schambye | Chief Executive Officer | Purchase | 3.0K | $5.11 | $15.3K |
Showing the 25 most recent of 31 Form 4 filings for Damora Therapeutics, Inc..
Most active DMRA insiders
- ORBIMED ADVISORS LLC7 filings
- Garrett Winslow6 filings
- Hans T. Schambye6 filings
- Jonathan Freve4 filings
- Lori Firmani3 filings
Ask anything about DMRA insider activity
Use Trabud's AI agent to query Damora Therapeutics, Inc.'s Form 4 history in plain English — "Show me DMRA CEO purchases this year" or compare it against any other ticker.
Open the AI agentDMRA insider trading FAQ
Are Damora Therapeutics, Inc. insiders buying or selling?
Across 31 SEC Form 4 filings, Damora Therapeutics, Inc. (DMRA) insiders reported 15 open-market purchases totaling $28.1M and 16 sales totaling $2.2M. That is a net buying position of $25.9M.
How many insiders trade DMRA stock?
9 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Damora Therapeutics, Inc.. The most recent filing was accepted on Jul 8, 2026.
Where does Trabud get DMRA insider trading data?
All DMRA insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.